期刊文献+

影响急性缺血性脑卒中溶栓治疗预后的因素 被引量:3

Factors influencing prognosis after thrombolysis for acute ischemic stroke
下载PDF
导出
摘要 溶栓治疗是改善急性缺血性脑卒中患者临床预后的有效治疗方法 ,但同时有再灌注损伤、症状性颅内出血、血管再闭塞等并发症,且起病至溶栓治疗时间、神经功能缺损程度、患者年龄、溶栓药物剂量、高血压、糖尿病、抗血小板药物等因素均可能增加溶栓并发症的发生及影响临床预后,在临床应用时应充分考虑影响预后的各种因素,以此指导溶栓治疗。现将临床常见影响溶栓治疗预后的因素进行综述。 Thrombolytic therapy is an effective method for improving clinical outcomes for patients with acute ischemic stroke,but at the same time it can bring some complications such as reperfusion injury,symptomatic intracranial hemorrhage,vascular re-occlusion and so on.A variety factors incuding onset to start of treatment(OTT),degree of neurological impairment,age,thrombolytic dose,hypertension,diabetes,anti-platelet drug may increase thrombolytic complications and affect the prognosis, so in clinical practice the prognostic factors should be fully considered to guide thrombolytic therapy.The common factors influencing prognosis of thrombolytic therapy are reviewed now.
出处 《中国当代医药》 2014年第35期180-182,186,共4页 China Modern Medicine
基金 国家卫生和计划生育委员会临床重点专科建设项目(卫办医政函[2012]649号)
关键词 脑卒中 溶栓 预后 Stroke Thrombolysis Prognosis
  • 相关文献

参考文献25

  • 1The National Instiute of Neurological Disorgers and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke[J].N Engl J Med, 1995,333 (24) : 1581- 1587.
  • 2Hacke W, Kaste M ,Bluhmki E ,et al.Thrombolysiswith al- teplase 3 to 4.5 hours after acute ischemic stroke[J].N Engl J Med,2008,359(13) : 1317-1329.
  • 3Del Zoppo GJ,JL Saver,EC Jauch,et al.Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advi- sory from the American Heart Association/American Stroke Association[J].Stroke, 2009,40 (8) : 2945-2948.
  • 4Wardlaw JM, Murray V, Berge E,et al.Thrombolysis for acute ischaemic stroke[J].Cochrane Database Syst Rev,2014,7: CD000213.
  • 5Lees KR,Bluhmki E,von Kummer R,et al.Time to treat- ment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS,ATLANTIS,NINDS, and EPITHET trials[J].Laneet, 2010,375 (9727): 1695-1703.
  • 6田阔,王丽华.急性脑梗死静脉溶栓治疗后颅内出血的最新研究进展[J].中风与神经疾病杂志,2013,30(8):766-768. 被引量:10
  • 7Luby M,Warach SJ,Nadareishvili Z,et al.Immediate changes in stroke lesion volumes post thrombolysis predict clinical outcome[J].Stroke, 2014,45 ( 11 ) : 3275-3279.
  • 8Starosciak AK, Linfante I, Walker G,et aLPredictors of poor outcome in acute ischemic stroke patients after successful recanalization[J].Circ Cardiovasc Qual Outcomes,2014,7: A10.
  • 9Wahlgren N,Ahmed N,Eriksson N ,et al.Muhivariable anal- ysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials:Safe Implementation of Thrombolysis in Stroke-Mon- itoring Study ( SITS-MOST ) [J].Stroke, 2008,39 (12) : 3316- 3322.
  • 10Sylaja PN, Cote R, Buchan AM ,et al.Thrombolysis in pa- tients older than 80 years with acute ischaemic stroke: Canadian Aheplase for Stroke Effectiveness Study[J].J Neu- rol Neurosurg Psychiatry, 2006,77 (7) : 826-829.

二级参考文献51

  • 1丁宏岩,董强.基底动脉梗死的治疗:动脉和静脉溶栓效果比较的系统分析[J].中国卒中杂志,2006,1(6):414-416. 被引量:127
  • 2Marler JR, Drott T, Droderick J, et al. DTissue plasminogen activator for acute ischemiic stroke. The National Institute of Neurological Disor- ders and Stroke rt-PA Stroke Study Group[ J]. N Eng! J Med, 1995,333(24):1581 -1587.
  • 3崔丽英,贾建平.神经病学(第六版)[M].北京:人民卫生出版社.2008.171-210.
  • 4Jeffrey L,Saver MD. Hemorrhage after thromholytic therapy for stroke [ J ]. Stroke,2007,38:2279 - 2283.
  • 5Werner Hacke, Markku Kaste, Erich Bluhmki, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [ J]. N Engl J Med ,2008,359:1317 - 1329.
  • 6Nils Wahlgren, Niaz Ahmed, Antoni Davalos, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST) an observation- al study[ J]. The Lancet,2007,369:275 -282.
  • 7Shinoyama M, Nakagawara J, Osato T, et al. Initial TIP map-defect of computed tomography pevfusion as a predictor of hemorrhagic transfor- mation of acute ischemic stroke [ J ]. Cerebrovasc Dis Extra,2013,3 : 14 - 25.
  • 8Nils Wahlgren, Niaz Ahmed, Antoni Davalos, et al. Thrombolysis with aheplase 3-4.5h after acute ischaemic stroke (SITS-ISTR) :an ob- servational study [ J ]. The Lancet,2008,372 : 1303 - 1309.
  • 9Peter U, Heuschmann MPH, Peter, et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombo- lytic therapy[ J]. JAMA,2004,292( 15 ) : 1831 - 1838.
  • 10Philip B. How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials, annals of the New York Academy of Sciences[ J]. ANNALS,2012,10 : 1749 - 6632.

共引文献60

同被引文献31

  • 1Pezzella FR, Picconi O, De Luca A, et al. Development of the Italian version of the National Institutes of Health Stroke Scale : It - NIHSS [ J ]. Stroke, 2009,40(7) :2557 -2559.
  • 2Folstein MF, Folstein SE, McHugh PR. " Mini - mental state". A prac- tical method for grading the cognitive state of patients for clinician[ J~. J Psychiat Res, 1975,12 ( 3 ) : 189 - 198.
  • 3Ashjazadeh N, Fathi M, Shariat A. Evaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes [J]. Iran J Med Sci, 2013,38(3) :233 -239.
  • 4Hernnann W, Obeid R. Homocysteine: a biomarker in neurodegenera- tive diseases[J]. Clin Chem Lab Med, 2011,49(3) :435 -441.
  • 5Mejia Mohamed EH, Tan KS, Ali JM, et al. I3" genotype of the meth- ylenetetrahydrofolate reductase C677T polymorphism is an important de- terminant for homocysteine levels in multi - ethnic Malaysian ischaemic stroke patients[ J ]. Ann Acad Med Singapore, 2011,40 (4) : 186 - 191.
  • 6The National Institute of Neurological Disorders and Stroke rt-PAStroke Study Group. Tissue plasminogen activator for acute ischemicstroke[J]. N Engl J Med,1995,333(24):1581-1587.
  • 7Hacke W, Kaste M, Bluhmki E, et a1. Thrombolysis with alteplase3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med,2008,359(13):1317-1329.
  • 8IST-3 collaborative group, Sandercock P, Wardlaw J M, et a1. Theb enefits a nd harms of intravenous t hrombolysis w ith recombinantt issue plasminogen activator w ithin 6 h of acute ischaemic stroke(the third international stroke trial [IST-3]): a randomized controlledtrial[J]. Lancet,2012,379(9834):2352-2363.
  • 9丁清琳.急性心肌梗死患者发病率及死亡率与性别年龄关系[J].安徽医学,2008,29(5):627-628. 被引量:24
  • 10茹铁周,刘庆军,刘峰,钱剑峰.瑞替普酶溶栓治疗急性心肌梗死致多脏器出血性休克一例[J].实用心脑肺血管病杂志,2008,16(9):68-69. 被引量:1

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部